Teladoc Health, Inc.
TDOC
$6.47
-$0.07-1.07%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -2.08% | -1.50% | -1.54% | -2.37% | -2.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.08% | -1.50% | -1.54% | -2.37% | -2.57% |
| Cost of Revenue | 2.19% | 2.49% | 2.71% | 1.02% | -0.78% |
| Gross Profit | -3.88% | -3.17% | -3.30% | -3.77% | -3.31% |
| SG&A Expenses | -7.24% | -5.39% | -4.94% | -2.02% | -1.60% |
| Depreciation & Amortization | 1.79% | 1.37% | -2.54% | -5.97% | -6.81% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.32% | -2.48% | -3.06% | -2.85% | -3.48% |
| Operating Income | 20.62% | 15.78% | 21.74% | 9.14% | 14.53% |
| Income Before Tax | 21.42% | 81.95% | 76.30% | 74.24% | 76.72% |
| Income Tax Expenses | 79.21% | -4.53% | -563.75% | -343.77% | -428.73% |
| Earnings from Continuing Operations | 14.45% | 83.09% | 79.99% | 77.23% | 79.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.45% | 83.09% | 79.99% | 77.23% | 79.38% |
| EBIT | 20.62% | 15.78% | 21.74% | 9.14% | 14.53% |
| EBITDA | 241.93% | 44.75% | 4.23% | -74.57% | -70.20% |
| EPS Basic | 16.88% | 83.75% | 80.61% | 77.85% | 79.86% |
| Normalized Basic EPS | 7.37% | 15.18% | 27.62% | 5.38% | 21.34% |
| EPS Diluted | 16.88% | 83.75% | 80.61% | 77.85% | 79.86% |
| Normalized Diluted EPS | 7.37% | 15.18% | 27.62% | 5.38% | 21.34% |
| Average Basic Shares Outstanding | 2.96% | 3.07% | 3.32% | 3.59% | 3.77% |
| Average Diluted Shares Outstanding | 2.96% | 3.07% | 3.32% | 3.59% | 3.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |